Blood marker for protein misfolding outperforms P-tau 217 as early predictor of Alzheimer'

Blood marker for protein misfolding outperforms P-tau 217 as early predictor of Alzheimer's disease. A study led by Professor Klaus Gerwert (PRODI, Ruhr University Bochum, Germany) has determined that the misfolding of the amyloid beta protein is the strongest blood-based predictor of Alzheimer's disease in the asymptomatic stage, indicating the risk of the disease years before it is clinically diagnosed and much earlier than the widely used plasma biomarker P-tau 217.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: A study led by Professor Klaus Gerwert (PRODI, Ruhr University Bochum, Germany) has determined that the misfolding of the amyloid beta protein is the strongest blood-based predictor of Alzheimer's disease in the asymptomatic stage, indicating the risk of the disease years before it is clinically diagnosed and much earlier than the widely used plasma biomarker P-tau 217.

• Ponto de atenção: blood.
• Ponto de atenção: marker.
• Ponto de atenção: protein.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.